{"nct_id":"NCT01295632","title":"Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049)","status":"COMPLETED","status_verified_date":"2015-08","start_date":"2011-02","start_date_type":null,"primary_completion_date":"2013-12","primary_completion_date_type":"ACTUAL","completion_date":"2015-08","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}